ArticleCancer reports (Hoboken, N.J.)2024

Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.

Riham Suleiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.